Pharmacokinetics and metabolism of intravenous pirfenidone in sheep

Michael L. Bruss, Scott D Stanley, Solomon B. Margolin, Shri N. Giri

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pirfenidone, a promising antifibrotic agent, was administered intravenously to six female sheep at 30mg/kg. Four sheep received 14C-pirfenidone simultaneously. Plasma and urine were obtained for assay of pirfenidone and its metabolites over two days, and tissues were obtained via necropsy. Samples were analysed for pirfenidone and metabolites using HPLC-MS and flow scintillation spectrometry. Plasma pirfenidone disappeared with first order kinetics with a clearance of 1.21/kg/h, half-life of 24 min, and distribution volume of 0.711/kg. After 48 h, the organs containing the largest quantity of 14C were lungs, liver and intestinal wall. Tissues with the highest concentration of 14 C were lung, kidney, brain, liver, lymph node and adipose. Metabolites found in plasma and urine were hydroxypirfenidone (half-life of 44min) and carboxypirfenidone. Additional metabolites found in urine were hydroxypirfenidone glucuronide and acetoxypirfenidone. Approximately, 80% of the tracer eventually appeared in the urine, and approximately 50% of it was in the form of identifiable metabolites. Less than 1 % of the dose appeared in the urine in the form of the parent drug. Quantitatively, most of the metabolites appeared in the urine within 2 h. Thus, the drug is rapidly and completely metabolized.

Original languageEnglish (US)
Pages (from-to)119-126
Number of pages8
JournalBiopharmaceutics and Drug Disposition
Volume29
Issue number2
DOIs
StatePublished - Mar 2008

Fingerprint

Sheep
Pharmacokinetics
Urine
Half-Life
Lung
Liver
Glucuronides
Pharmaceutical Preparations
pirfenidone
Spectrum Analysis
Lymph Nodes
High Pressure Liquid Chromatography
Kidney
Brain

Keywords

  • Metabolism
  • Pharmacokinetics
  • Pirfenidone
  • Sheep

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacokinetics and metabolism of intravenous pirfenidone in sheep. / Bruss, Michael L.; Stanley, Scott D; Margolin, Solomon B.; Giri, Shri N.

In: Biopharmaceutics and Drug Disposition, Vol. 29, No. 2, 03.2008, p. 119-126.

Research output: Contribution to journalArticle

Bruss, Michael L. ; Stanley, Scott D ; Margolin, Solomon B. ; Giri, Shri N. / Pharmacokinetics and metabolism of intravenous pirfenidone in sheep. In: Biopharmaceutics and Drug Disposition. 2008 ; Vol. 29, No. 2. pp. 119-126.
@article{ed223a4ca9e24766845f8c5d1388c5bc,
title = "Pharmacokinetics and metabolism of intravenous pirfenidone in sheep",
abstract = "Pirfenidone, a promising antifibrotic agent, was administered intravenously to six female sheep at 30mg/kg. Four sheep received 14C-pirfenidone simultaneously. Plasma and urine were obtained for assay of pirfenidone and its metabolites over two days, and tissues were obtained via necropsy. Samples were analysed for pirfenidone and metabolites using HPLC-MS and flow scintillation spectrometry. Plasma pirfenidone disappeared with first order kinetics with a clearance of 1.21/kg/h, half-life of 24 min, and distribution volume of 0.711/kg. After 48 h, the organs containing the largest quantity of 14C were lungs, liver and intestinal wall. Tissues with the highest concentration of 14 C were lung, kidney, brain, liver, lymph node and adipose. Metabolites found in plasma and urine were hydroxypirfenidone (half-life of 44min) and carboxypirfenidone. Additional metabolites found in urine were hydroxypirfenidone glucuronide and acetoxypirfenidone. Approximately, 80{\%} of the tracer eventually appeared in the urine, and approximately 50{\%} of it was in the form of identifiable metabolites. Less than 1 {\%} of the dose appeared in the urine in the form of the parent drug. Quantitatively, most of the metabolites appeared in the urine within 2 h. Thus, the drug is rapidly and completely metabolized.",
keywords = "Metabolism, Pharmacokinetics, Pirfenidone, Sheep",
author = "Bruss, {Michael L.} and Stanley, {Scott D} and Margolin, {Solomon B.} and Giri, {Shri N.}",
year = "2008",
month = "3",
doi = "10.1002/bdd.595",
language = "English (US)",
volume = "29",
pages = "119--126",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics and metabolism of intravenous pirfenidone in sheep

AU - Bruss, Michael L.

AU - Stanley, Scott D

AU - Margolin, Solomon B.

AU - Giri, Shri N.

PY - 2008/3

Y1 - 2008/3

N2 - Pirfenidone, a promising antifibrotic agent, was administered intravenously to six female sheep at 30mg/kg. Four sheep received 14C-pirfenidone simultaneously. Plasma and urine were obtained for assay of pirfenidone and its metabolites over two days, and tissues were obtained via necropsy. Samples were analysed for pirfenidone and metabolites using HPLC-MS and flow scintillation spectrometry. Plasma pirfenidone disappeared with first order kinetics with a clearance of 1.21/kg/h, half-life of 24 min, and distribution volume of 0.711/kg. After 48 h, the organs containing the largest quantity of 14C were lungs, liver and intestinal wall. Tissues with the highest concentration of 14 C were lung, kidney, brain, liver, lymph node and adipose. Metabolites found in plasma and urine were hydroxypirfenidone (half-life of 44min) and carboxypirfenidone. Additional metabolites found in urine were hydroxypirfenidone glucuronide and acetoxypirfenidone. Approximately, 80% of the tracer eventually appeared in the urine, and approximately 50% of it was in the form of identifiable metabolites. Less than 1 % of the dose appeared in the urine in the form of the parent drug. Quantitatively, most of the metabolites appeared in the urine within 2 h. Thus, the drug is rapidly and completely metabolized.

AB - Pirfenidone, a promising antifibrotic agent, was administered intravenously to six female sheep at 30mg/kg. Four sheep received 14C-pirfenidone simultaneously. Plasma and urine were obtained for assay of pirfenidone and its metabolites over two days, and tissues were obtained via necropsy. Samples were analysed for pirfenidone and metabolites using HPLC-MS and flow scintillation spectrometry. Plasma pirfenidone disappeared with first order kinetics with a clearance of 1.21/kg/h, half-life of 24 min, and distribution volume of 0.711/kg. After 48 h, the organs containing the largest quantity of 14C were lungs, liver and intestinal wall. Tissues with the highest concentration of 14 C were lung, kidney, brain, liver, lymph node and adipose. Metabolites found in plasma and urine were hydroxypirfenidone (half-life of 44min) and carboxypirfenidone. Additional metabolites found in urine were hydroxypirfenidone glucuronide and acetoxypirfenidone. Approximately, 80% of the tracer eventually appeared in the urine, and approximately 50% of it was in the form of identifiable metabolites. Less than 1 % of the dose appeared in the urine in the form of the parent drug. Quantitatively, most of the metabolites appeared in the urine within 2 h. Thus, the drug is rapidly and completely metabolized.

KW - Metabolism

KW - Pharmacokinetics

KW - Pirfenidone

KW - Sheep

UR - http://www.scopus.com/inward/record.url?scp=42149193768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149193768&partnerID=8YFLogxK

U2 - 10.1002/bdd.595

DO - 10.1002/bdd.595

M3 - Article

C2 - 18176939

AN - SCOPUS:42149193768

VL - 29

SP - 119

EP - 126

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 2

ER -